KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Bio-Rad Laboratories (BIO) over the last 17 years, with Q4 2025 value amounting to $517.0 million.

  • Bio-Rad Laboratories' Total Current Liabilities rose 1051.73% to $517.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $517.0 million, marking a year-over-year increase of 1051.73%. This contributed to the annual value of $517.0 million for FY2025, which is 1051.73% up from last year.
  • As of Q4 2025, Bio-Rad Laboratories' Total Current Liabilities stood at $517.0 million, which was up 1051.73% from $522.3 million recorded in Q3 2025.
  • Over the past 5 years, Bio-Rad Laboratories' Total Current Liabilities peaked at $680.9 million during Q4 2021, and registered a low of $466.2 million during Q1 2024.
  • Its 5-year average for Total Current Liabilities is $559.8 million, with a median of $563.4 million in 2022.
  • In the last 5 years, Bio-Rad Laboratories' Total Current Liabilities plummeted by 3666.47% in 2021 and then soared by 1271.95% in 2025.
  • Quarter analysis of 5 years shows Bio-Rad Laboratories' Total Current Liabilities stood at $680.9 million in 2021, then decreased by 16.48% to $568.7 million in 2022, then decreased by 8.07% to $522.8 million in 2023, then decreased by 10.52% to $467.8 million in 2024, then grew by 10.52% to $517.0 million in 2025.
  • Its Total Current Liabilities was $517.0 million in Q4 2025, compared to $522.3 million in Q3 2025 and $548.9 million in Q2 2025.